{"entity":{"type":"insider","cik":"0001394875","url":"/insider/0001394875","json_url":"/insider/0001394875.json","name":"Labrucherie Gil M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":52,"first":"2008-11-18","last":"2025-02-27","span_basis":"filed_date"},"name_variants":[{"name":"Labrucherie Gil M","source":"filing","n_filings":52,"first_seen":"2008-11-18","last_seen":"2025-02-27"}],"transactions":[{"id":4980706,"accession":"0000950170-25-029330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-029330","line_url":"/filing/0000950170-25-029330#line-2","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3718.0,"shares_display":"3,718","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":21750.3,"total_display":"21,750.30","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-27","scope":"insider"},{"id":4980701,"accession":"0000950170-25-029330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-029330","line_url":"/filing/0000950170-25-029330#line-1","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6282.0,"shares_display":"6,282","price_per_share":5.59,"price_display":"5.59","price_state":"stated","total_value":35116.38,"total_display":"35,116.38","shares_owned_after":36282.0,"shares_owned_after_display":"36,282","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider"},{"id":4790695,"accession":"0000950170-25-025039","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-025039","line_url":"/filing/0000950170-25-025039#line-3","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":29250.0,"total_display":"29,250.00","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-21","scope":"insider"},{"id":4790692,"accession":"0000950170-25-025039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-025039","line_url":"/filing/0000950170-25-025039#line-2","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14500.0,"shares_display":"14,500","price_per_share":5.8782,"price_display":"5.88","price_state":"stated","total_value":85233.9,"total_display":"85,233.90","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":4790685,"accession":"0000950170-25-025039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025039","line_url":"/filing/0000950170-25-025039#line-1","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":5.506,"price_display":"5.51","price_state":"stated","total_value":57813.0,"total_display":"57,813.00","shares_owned_after":10500.0,"shares_owned_after_display":"10,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":6429738,"accession":"0001209191-22-029899","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-029899","line_url":"/filing/0001209191-22-029899#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17448.0,"shares_display":"17,448","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":68919.6,"total_display":"68,919.60","shares_owned_after":312905.0,"shares_owned_after_display":"312,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":9292150,"accession":"0001567619-22-009789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-009789","line_url":"/filing/0001567619-22-009789#line-1","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Rezolute, Inc.","issuer_ticker":"RZLT","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52631.0,"shares_display":"52,631","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":199997.8,"total_display":"199,997.80","shares_owned_after":53572.0,"shares_owned_after_display":"53,572","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-09","scope":"insider"},{"id":6633625,"accession":"0001567619-22-009699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-009699","line_url":"/filing/0001567619-22-009699#line-1","is_derivative":false,"issuer_cik":"0001394875","issuer_name":"Rezolute, Inc.","issuer_ticker":"RZLT","issuer_name_source":null,"issuer_url":"/issuer/0001394875","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52631.0,"shares_display":"52,631","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":199997.8,"total_display":"199,997.80","shares_owned_after":52631.0,"shares_owned_after_display":"52,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-06","scope":"insider"},{"id":6481246,"accession":"0001209191-22-011436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011436","line_url":"/filing/0001209191-22-011436#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7579.0,"shares_display":"7,579","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":82990.05,"total_display":"82,990.05","shares_owned_after":301603.0,"shares_owned_after_display":"301,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4386793,"accession":"0001209191-21-065592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065592","line_url":"/filing/0001209191-21-065592#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.69,"price_display":"12.69","price_state":"stated","total_value":38070.0,"total_display":"38,070.00","shares_owned_after":256682.0,"shares_owned_after_display":"256,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":4386785,"accession":"0001209191-21-065592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065592","line_url":"/filing/0001209191-21-065592#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21149.0,"shares_display":"21,149","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":278320.84,"total_display":"278,320.84","shares_owned_after":259682.0,"shares_owned_after_display":"259,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":4142192,"accession":"0001209191-21-052384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052384","line_url":"/filing/0001209191-21-052384#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":13.56,"price_display":"13.56","price_state":"stated","total_value":40680.0,"total_display":"40,680.00","shares_owned_after":240231.0,"shares_owned_after_display":"240,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-18","scope":"insider"},{"id":4142188,"accession":"0001209191-21-052384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052384","line_url":"/filing/0001209191-21-052384#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7867.0,"shares_display":"7,867","price_per_share":13.83,"price_display":"13.83","price_state":"stated","total_value":108800.61,"total_display":"108,800.61","shares_owned_after":243231.0,"shares_owned_after_display":"243,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4785197,"accession":"0001209191-21-034184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034184","line_url":"/filing/0001209191-21-034184#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7898.0,"shares_display":"7,898","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":144533.4,"total_display":"144,533.40","shares_owned_after":251098.0,"shares_owned_after_display":"251,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":4362671,"accession":"0001209191-21-012119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012119","line_url":"/filing/0001209191-21-012119#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7977.0,"shares_display":"7,977","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":178445.49,"total_display":"178,445.49","shares_owned_after":258996.0,"shares_owned_after_display":"258,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4362155,"accession":"0001209191-21-007942","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-007942","line_url":"/filing/0001209191-21-007942#line-9","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":19.81,"price_display":"19.81","price_state":"stated","total_value":990500.0,"total_display":"990,500.00","shares_owned_after":266973.0,"shares_owned_after_display":"266,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-04","scope":"insider"},{"id":4362150,"accession":"0001209191-21-007942","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-007942","line_url":"/filing/0001209191-21-007942#line-7","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":19.61,"price_display":"19.61","price_state":"stated","total_value":980500.0,"total_display":"980,500.00","shares_owned_after":266973.0,"shares_owned_after_display":"266,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":4362142,"accession":"0001209191-21-007942","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-007942","line_url":"/filing/0001209191-21-007942#line-4","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41135.0,"shares_display":"41,135","price_per_share":19.97,"price_display":"19.97","price_state":"stated","total_value":821465.95,"total_display":"821,465.95","shares_owned_after":275838.0,"shares_owned_after_display":"275,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":4362138,"accession":"0001209191-21-007942","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-007942","line_url":"/filing/0001209191-21-007942#line-3","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6932.0,"shares_display":"6,932","price_per_share":20.96,"price_display":"20.96","price_state":"stated","total_value":145294.72,"total_display":"145,294.72","shares_owned_after":268906.0,"shares_owned_after_display":"268,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":4362135,"accession":"0001209191-21-007942","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-007942","line_url":"/filing/0001209191-21-007942#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1933.0,"shares_display":"1,933","price_per_share":21.66,"price_display":"21.66","price_state":"stated","total_value":41868.78,"total_display":"41,868.78","shares_owned_after":266973.0,"shares_owned_after_display":"266,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":2739390,"accession":"0001209191-20-059241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059241","line_url":"/filing/0001209191-20-059241#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8276.0,"shares_display":"8,276","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":140112.68,"total_display":"140,112.68","shares_owned_after":226973.0,"shares_owned_after_display":"226,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2220769,"accession":"0001209191-20-051389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051389","line_url":"/filing/0001209191-20-051389#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":39920.0,"total_display":"39,920.00","shares_owned_after":235249.0,"shares_owned_after_display":"235,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-21","scope":"insider"},{"id":2181416,"accession":"0001209191-20-047613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047613","line_url":"/filing/0001209191-20-047613#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.68,"price_display":"19.68","price_state":"stated","total_value":39360.0,"total_display":"39,360.00","shares_owned_after":237249.0,"shares_owned_after_display":"237,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2181413,"accession":"0001209191-20-047613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047613","line_url":"/filing/0001209191-20-047613#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6245.0,"shares_display":"6,245","price_per_share":19.67,"price_display":"19.67","price_state":"stated","total_value":122839.15,"total_display":"122,839.15","shares_owned_after":239249.0,"shares_owned_after_display":"239,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3256993,"accession":"0001209191-20-031014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031014","line_url":"/filing/0001209191-20-031014#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":22.62,"price_display":"22.62","price_state":"stated","total_value":45240.0,"total_display":"45,240.00","shares_owned_after":245494.0,"shares_owned_after_display":"245,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-20","scope":"insider"},{"id":3256990,"accession":"0001209191-20-031014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031014","line_url":"/filing/0001209191-20-031014#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5727.0,"shares_display":"5,727","price_per_share":22.51,"price_display":"22.51","price_state":"stated","total_value":128914.77,"total_display":"128,914.77","shares_owned_after":247494.0,"shares_owned_after_display":"247,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2333843,"accession":"0001209191-20-011258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-011258","line_url":"/filing/0001209191-20-011258#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5938.0,"shares_display":"5,938","price_per_share":22.35,"price_display":"22.35","price_state":"stated","total_value":132714.3,"total_display":"132,714.30","shares_owned_after":253221.0,"shares_owned_after_display":"253,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":7873289,"accession":"0001209191-19-057489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-057489","line_url":"/filing/0001209191-19-057489#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8863.0,"shares_display":"8,863","price_per_share":17.97,"price_display":"17.97","price_state":"stated","total_value":159268.11,"total_display":"159,268.11","shares_owned_after":219009.0,"shares_owned_after_display":"219,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7885330,"accession":"0001209191-19-056807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056807","line_url":"/filing/0001209191-19-056807#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":19.79,"price_display":"19.79","price_state":"stated","total_value":494750.0,"total_display":"494,750.00","shares_owned_after":227872.0,"shares_owned_after_display":"227,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-15","scope":"insider"},{"id":8519783,"accession":"0001209191-19-053497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053497","line_url":"/filing/0001209191-19-053497#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP, COO & CFO)","officer_title":"SVP, COO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.83,"price_display":"15.83","price_state":"stated","total_value":395750.0,"total_display":"395,750.00","shares_owned_after":227872.0,"shares_owned_after_display":"227,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-17","scope":"insider"},{"id":7951206,"accession":"0001209191-19-050149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050149","line_url":"/filing/0001209191-19-050149#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":20.52,"price_display":"20.52","price_state":"stated","total_value":513000.0,"total_display":"513,000.00","shares_owned_after":152872.0,"shares_owned_after_display":"152,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-18","scope":"insider"},{"id":8676992,"accession":"0001209191-19-046715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046715","line_url":"/filing/0001209191-19-046715#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5063.0,"shares_display":"5,063","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":91893.45,"total_display":"91,893.45","shares_owned_after":122872.0,"shares_owned_after_display":"122,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-19","scope":"insider"},{"id":7872159,"accession":"0001209191-19-046428","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046428","line_url":"/filing/0001209191-19-046428#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.79,"price_display":"17.79","price_state":"stated","total_value":444750.0,"total_display":"444,750.00","shares_owned_after":127935.0,"shares_owned_after_display":"127,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":7871886,"accession":"0001209191-19-041988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-041988","line_url":"/filing/0001209191-19-041988#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":34.57,"price_display":"34.57","price_state":"stated","total_value":864250.0,"total_display":"864,250.00","shares_owned_after":127935.0,"shares_owned_after_display":"127,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"},{"id":7950123,"accession":"0001209191-19-038099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-038099","line_url":"/filing/0001209191-19-038099#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":33.71,"price_display":"33.71","price_state":"stated","total_value":842750.0,"total_display":"842,750.00","shares_owned_after":127935.0,"shares_owned_after_display":"127,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":8646132,"accession":"0001209191-19-031187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-031187","line_url":"/filing/0001209191-19-031187#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3767.0,"shares_display":"3,767","price_per_share":31.37,"price_display":"31.37","price_state":"stated","total_value":118170.79,"total_display":"118,170.79","shares_owned_after":127935.0,"shares_owned_after_display":"127,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-17","scope":"insider"},{"id":7866346,"accession":"0001209191-19-012334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012334","line_url":"/filing/0001209191-19-012334#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3592.0,"shares_display":"3,592","price_per_share":42.39,"price_display":"42.39","price_state":"stated","total_value":152264.88,"total_display":"152,264.88","shares_owned_after":131702.0,"shares_owned_after_display":"131,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":6370630,"accession":"0001209191-18-059290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059290","line_url":"/filing/0001209191-18-059290#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6515.0,"shares_display":"6,515","price_per_share":38.25,"price_display":"38.25","price_state":"stated","total_value":249198.75,"total_display":"249,198.75","shares_owned_after":106544.0,"shares_owned_after_display":"106,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-19","scope":"insider"},{"id":6585048,"accession":"0001209191-18-031594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031594","line_url":"/filing/0001209191-18-031594#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4941.0,"shares_display":"4,941","price_per_share":83.39,"price_display":"83.39","price_state":"stated","total_value":412029.99,"total_display":"412,029.99","shares_owned_after":94798.0,"shares_owned_after_display":"94,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider"},{"id":6100422,"accession":"0001209191-18-027942","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-027942","line_url":"/filing/0001209191-18-027942#line-6","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":82.86,"price_display":"82.86","price_state":"stated","total_value":2485800.0,"total_display":"2,485,800.00","shares_owned_after":99739.0,"shares_owned_after_display":"99,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-03","filed_date":"2018-05-03","scope":"insider"},{"id":6100416,"accession":"0001209191-18-027942","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-027942","line_url":"/filing/0001209191-18-027942#line-4","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":85.63,"price_display":"85.63","price_state":"stated","total_value":2568900.0,"total_display":"2,568,900.00","shares_owned_after":99739.0,"shares_owned_after_display":"99,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-02","filed_date":"2018-05-03","scope":"insider"},{"id":6100409,"accession":"0001209191-18-027942","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-027942","line_url":"/filing/0001209191-18-027942#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":83.65,"price_display":"83.65","price_state":"stated","total_value":2509500.0,"total_display":"2,509,500.00","shares_owned_after":99739.0,"shares_owned_after_display":"99,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-03","scope":"insider"},{"id":6452715,"accession":"0001209191-18-011592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011592","line_url":"/filing/0001209191-18-011592#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3477.0,"shares_display":"3,477","price_per_share":82.94,"price_display":"82.94","price_state":"stated","total_value":288382.38,"total_display":"288,382.38","shares_owned_after":99739.0,"shares_owned_after_display":"99,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-20","scope":"insider"},{"id":5282378,"accession":"0001209191-17-055360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055360","line_url":"/filing/0001209191-17-055360#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":24.45,"price_display":"24.45","price_state":"stated","total_value":2934000.0,"total_display":"2,934,000.00","shares_owned_after":63414.0,"shares_owned_after_display":"63,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-03","scope":"insider"},{"id":4267875,"accession":"0001209191-17-049666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049666","line_url":"/filing/0001209191-17-049666#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3177.0,"shares_display":"3,177","price_per_share":19.32,"price_display":"19.32","price_state":"stated","total_value":61379.64,"total_display":"61,379.64","shares_owned_after":63414.0,"shares_owned_after_display":"63,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-18","scope":"insider"},{"id":4658403,"accession":"0001209191-17-033769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033769","line_url":"/filing/0001209191-17-033769#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3179.0,"shares_display":"3,179","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":62149.45,"total_display":"62,149.45","shares_owned_after":66091.0,"shares_owned_after_display":"66,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-18","scope":"insider"},{"id":4622666,"accession":"0001209191-17-018033","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-018033","line_url":"/filing/0001209191-17-018033#line-6","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.21,"price_display":"15.21","price_state":"stated","total_value":380250.0,"total_display":"380,250.00","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-03","scope":"insider"},{"id":4622662,"accession":"0001209191-17-018033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-018033","line_url":"/filing/0001209191-17-018033#line-5","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7494.0,"shares_display":"7,494","price_per_share":15.21,"price_display":"15.21","price_state":"stated","total_value":113983.74,"total_display":"113,983.74","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-03","scope":"insider"},{"id":4622650,"accession":"0001209191-17-018033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-018033","line_url":"/filing/0001209191-17-018033#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":167506.0,"shares_display":"167,506","price_per_share":15.15,"price_display":"15.15","price_state":"stated","total_value":2537715.9,"total_display":"2,537,715.90","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-03","scope":"insider"},{"id":4828698,"accession":"0001209191-17-012405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-012405","line_url":"/filing/0001209191-17-012405#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001394875","owner_name":"Labrucherie Gil M","owner_url":"/insider/0001394875","role":"Officer (SVP & Chief Financial Officer)","officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2359.0,"shares_display":"2,359","price_per_share":13.14,"price_display":"13.14","price_state":"stated","total_value":30997.26,"total_display":"30,997.26","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"}],"next_cursor":"2017-02-16|4828698","ledger_fault":false,"count":{"value":68,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":61,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":68},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001984086","name":"Septerna, Inc.","url":"/issuer/0001984086","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2025-02-21","last_seen":"2025-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (SVP, COO & CFO)","n_filings":48,"first_seen":"2008-11-18","last_seen":"2022-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001509261","name":"Rezolute, Inc.","url":"/issuer/0001509261","role":"Director","n_filings":2,"first_seen":"2022-05-06","last_seen":"2022-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001394875","retrieved_at":"2026-08-21T09:28:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}